July 21 (Reuters) - Roche's (ROG.S), opens new tab head of diagnostics, Thomas Schinecker, is to take over as group chief executive next year, replacing Severin Schwan, who will become chairman ...

Dec 29 (Reuters) - Swiss drugmaker Roche said on Friday it has agreed to buy LumiraDx's Point of Care diagnostics platform business for about $295 million. Shares of LumiraDx rose about 20% ...

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis-based diagnostics unit. The Swiss pharmaceutical and diagnostics giant ...

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

The head of Roche Diagnostics North America region, which is headquartered in Indianapolis, has been promoted to oversee the Switzerland-based company’s entire diagnostics division. Matt Sause ...

Roche is set to invest $50bn in pharmaceuticals and diagnostics in the US over the next five years to bolster the company's presence in the country. The commitment includes 15 research and ...

A flurry of mergers and acquisitions in the pharma space at the end of 2023 ended with a $295 million deal by Roche to buy a point-of-care diagnostics platform from LumiraDx, which recently went ...

INDIANAPOLIS, May 12, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today it plans to invest up to $550 million in its Diagnostics site in Indianapolis by 2030. The site will ...